Genomma Lab Internacional SAB de CV (LABB) Ratios
Genomma Lab Internacional SAB de CV Ratios
MX:LABB's free cash flow for Q3 2026 was $372.85M. For the 2026 fiscal year, MX:LABB's free cash flow was decreased by $-24.78M and operating cash flow was $397.63M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.77 | 1.85 | 1.61 | 1.21 | 1.75 |
| Quick Ratio | 1.52 | 1.51 | 1.32 | 0.95 | 1.42 |
| Cash Ratio | 0.39 | 0.35 | 0.22 | 0.16 | 0.19 |
| Solvency Ratio | 0.16 | 0.15 | 0.12 | 0.14 | 0.13 |
| Operating Cash Flow Ratio | 0.28 | 0.46 | 0.01 | 0.18 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 0.73 | 2.22 | 0.05 | 0.02 | 0.03 |
| Net Current Asset Value | $ 115.34M | $ -66.42M | $ 10.01B | $ -7.27M | $ 2.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.28 | 5.13 | 0.30 | 0.28 |
| Debt-to-Equity Ratio | 0.69 | 0.60 | 11.29 | 0.63 | 0.59 |
| Debt-to-Capital Ratio | 0.41 | 0.37 | 0.92 | 0.39 | 0.37 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.32 | 0.88 | 0.13 | 0.28 |
| Financial Leverage Ratio | 2.15 | 2.11 | 2.20 | 2.13 | 2.14 |
| Debt Service Coverage Ratio | 0.77 | 1.48 | -0.17 | 0.03 | 0.05 |
| Interest Coverage Ratio | 4.72 | 4.42 | 0.23 | 6.28 | 6.74 |
| Debt to Market Cap | 0.43 | 0.26 | 7.70 | 5.90 | 2.14 |
| Interest Debt Per Share | 8.65 | 7.54 | 7.38 | 0.36 | 0.31 |
| Net Debt to EBITDA | 1.33 | 1.02 | 28.55 | 1.40 | 1.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.84% | 64.12% | 61.22% | 60.43% | 61.75% |
| EBIT Margin | 18.42% | 20.31% | 15.84% | 16.41% | 17.80% |
| EBITDA Margin | 20.58% | 22.24% | 17.23% | 20.99% | 18.90% |
| Operating Profit Margin | 21.43% | 21.08% | 19.49% | 19.64% | 19.35% |
| Pretax Profit Margin | 13.87% | 15.54% | 177.48% | 13.28% | 14.93% |
| Net Profit Margin | 9.16% | 8.02% | 6.59% | 8.26% | 8.44% |
| Continuous Operations Profit Margin | 9.16% | 11.24% | 111.91% | 8.12% | 173.44% |
| Net Income Per EBT | 66.05% | 51.65% | 3.71% | 62.18% | 56.56% |
| EBT Per EBIT | 64.73% | 73.71% | 910.57% | 67.64% | 77.16% |
| Return on Assets (ROA) | 6.74% | 6.49% | 5.25% | 6.43% | 6.07% |
| Return on Equity (ROE) | 14.47% | 13.72% | 11.57% | 13.68% | 12.98% |
| Return on Capital Employed (ROCE) | 22.65% | 23.80% | -3.50% | 26.96% | 20.02% |
| Return on Invested Capital (ROIC) | 12.78% | 15.89% | 0.74% | 1.89% | 3.11% |
| Return on Tangible Assets | 8.78% | 8.78% | -1.71% | -1.76% | -1.55% |
| Earnings Yield | 9.22% | 6.02% | 7.95% | 8.57% | 6.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.22 | 4.04 | 4.31 | 2.49 | 0.65 |
| Payables Turnover | 4.12 | 3.84 | 3.47 | 0.19 | 0.20 |
| Inventory Turnover | 3.54 | 3.07 | 0.20 | 2.78 | 2.69 |
| Fixed Asset Turnover | 4.51 | 5.23 | 0.28 | 4.68 | 4.60 |
| Asset Turnover | 0.74 | 0.81 | 0.80 | 0.78 | 0.72 |
| Working Capital Turnover Ratio | 3.15 | 3.89 | 0.47 | 5.05 | 2.94 |
| Cash Conversion Cycle | 128.01 | 114.36 | 1834.53 | -1636.64 | -1124.93 |
| Days of Sales Outstanding | 113.50 | 90.42 | 84.70 | 146.79 | 561.14 |
| Days of Inventory Outstanding | 103.03 | 118.98 | 1854.99 | 131.44 | 135.67 |
| Days of Payables Outstanding | 88.52 | 95.04 | 105.17 | 1914.86 | 1821.73 |
| Operating Cycle | 216.53 | 209.40 | 1939.69 | 278.23 | 696.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.11 | 3.10 | 0.10 | 0.09 | 0.05 |
| Free Cash Flow Per Share | 2.08 | 2.41 | 0.08 | 0.06 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | 2.54 | 2.09 | 0.16 | 1.39 | 0.91 |
| Capital Expenditure Coverage Ratio | 76.98 | 4.49 | 6.71 | 3.94 | 1.33 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.47 | 0.02 | 0.26 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.16 | 0.10 | 0.10 | 0.07 |
| Free Cash Flow Yield | 11.63% | 9.51% | 9.26% | 7.66% | 1.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.85 | 16.56 | 12.58 | 11.67 | 16.61 |
| Price-to-Sales (P/S) Ratio | 0.99 | 1.33 | 0.83 | 0.96 | 1.40 |
| Price-to-Book (P/B) Ratio | 1.57 | 2.28 | 1.46 | 1.60 | 2.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.60 | 10.51 | 10.80 | 13.06 | 78.12 |
| Price-to-Operating Cash Flow Ratio | 8.49 | 8.17 | 8.54 | 9.75 | 19.49 |
| Price-to-Earnings Growth (PEG) Ratio | 1.38 | 0.47 | -1.80 | 0.87 | -1.81 |
| Enterprise Value Multiple | 6.16 | 7.01 | 33.36 | 5.99 | 9.03 |
| Enterprise Value | 22.23B | 29.01B | 5.57B | 1.08B | 1.29B |
| EV to EBITDA | 6.16 | 7.01 | 33.36 | 5.99 | 9.03 |
| EV to Sales | 1.27 | 1.56 | 5.75 | 1.26 | 1.71 |
| EV to Free Cash Flow | 10.96 | 12.30 | 74.85 | 17.04 | 95.00 |
| EV to Operating Cash Flow | 10.82 | 9.56 | 59.15 | 12.71 | 23.70 |
| Tangible Book Value Per Share | 5.73 | 4.97 | -4.61 | -4.66 | -4.64 |
| Shareholders’ Equity Per Share | 11.41 | 11.12 | 0.58 | 0.52 | 0.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.34 | 0.28 | 0.37 | 0.39 | 0.40 |
| Revenue Per Share | 18.01 | 19.02 | 1.01 | 0.87 | 0.75 |
| Net Income Per Share | 1.65 | 1.53 | 0.07 | 0.07 | 0.06 |
| Tax Burden | 0.66 | 0.52 | 0.04 | 0.62 | 0.57 |
| Interest Burden | 0.75 | 0.77 | 11.20 | 0.81 | 0.84 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.40 | 0.43 | 7.05 | 8.03 | 8.71 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.28 | 1.42 | 0.09 | 1.20 | 0.85 |
Currency in MXN
